Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE turns down Opdivo/Yervoy combo for kidney cancer

pharmatimesDecember 11, 2018

Tag: Opdivo , nivolumab , Yervoy

PharmaSources Customer Service